Skip to main content

Animations

MJFF Publications

6581 - 6590 of 8404 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • Summary Details
    OPEN
    Title: Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1621218114
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing
    Journal Name: Genome Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s13059-017-1147-9
    Citation Count: 108
  • Summary Details
    OPEN
    Title: Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0007-3
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12478
    Citation Count: 75
  • Summary Details
    OPEN
    Title: The human subthalamic nucleus and globus pallidus internus differentially encode reward during action control
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23496
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012
    Best OA location URL:
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner
    Journal Name: Biochimica et Biophysica Acta (BBA) - General Subjects
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021
    Best OA location URL:
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Leucine-Rich Repeat Kinase 2 (Lrrk2)-Sensitive Na+/K+ ATPase Activity in Dendritic Cells
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/srep41117
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0154-3
    Citation Count: 216
  • Summary Details
    OPEN
    Title: An early and late peak in microglial activation in Alzheimer’s disease trajectory
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/aww349
    Citation Count: 368
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.